Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Heart Transplantation

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 477 articles:
HTML format



Single Articles


    October 2021
  1. SUJINO Y, Doi SN, Ikeda Y, Tabata S, et al
    Successful treatment of a primary central nervous system lymphoproliferative disorder post-heart transplantation with modification of the immunosuppressive regimen used: A case report.
    J Heart Lung Transplant. 2021 Oct 22. pii: S1053-2498(21)02547.
    PubMed    


  2. CHEN S, Bensen R, Hollander SA, Sganga D, et al
    Response to JHLT-D-21-00302 "Failing Fontan - heart or heart-liver transplant: The jury is (still) out?"
    J Heart Lung Transplant. 2021;40:1248-1249.
    PubMed    


    September 2021
  3. BUTTO A, Mao CY, Wright L, Wetzel M, et al
    Relationship of ventricular assist device support duration with pediatric heart transplant outcomes.
    J Heart Lung Transplant. 2021 Sep 29. pii: S1053-2498(21)02521.
    PubMed     Abstract available


  4. CASCINO TM, Stehlik J, Cherikh WS, Cheng Y, et al
    A challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated U.S. heart transplant allocation policy.
    J Heart Lung Transplant. 2021 Sep 16. pii: S1053-2498(21)02494.
    PubMed     Abstract available


  5. WAYDA B, Sandhu AT, Parizo J, Teuteberg JJ, et al
    Cost-effectiveness and system-wide impact of using Hepatitis C-viremic donors for heart transplant.
    J Heart Lung Transplant. 2021 Sep 13. pii: S1053-2498(21)02491.
    PubMed     Abstract available


  6. AMDANI S
    Failing Fontan-heart or heart-liver transplant: The jury is (still) out?
    J Heart Lung Transplant. 2021;40:1020.
    PubMed    


    August 2021
  7. JACKSON KC, Youmans QR, Wu T, Harap R, et al
    Heart transplantation outcomes in cardiac sarcoidosis.
    J Heart Lung Transplant. 2021 Aug 30. pii: S1053-2498(21)02484.
    PubMed     Abstract available


  8. PELED Y, Ram E, Lavee J, Segev A, et al
    Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience.
    J Heart Lung Transplant. 2021 Aug 28. pii: S1053-2498(21)02481.
    PubMed     Abstract available


  9. HALLORAN PF, Madill-Thomsen K, Aliabadi-Zuckermann AZ, Cadeiras M, et al
    Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
    J Heart Lung Transplant. 2021 Aug 26. pii: S1053-2498(21)02458.
    PubMed     Abstract available


  10. GODOWN J, Cantor R, Koehl D, Cummings E, et al
    Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry.
    J Heart Lung Transplant. 2021 Aug 19. pii: S1053-2498(21)02456.
    PubMed     Abstract available


  11. TRUBY LK, Kwee LC, Agarwal R, Grass E, et al
    Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    J Heart Lung Transplant. 2021 Aug 11. pii: S1053-2498(21)02443.
    PubMed     Abstract available


  12. DOLGNER SJ, Nguyen VP, Cowger J, Dardas TF, et al
    Accuracy of risk models used for public reporting of heart transplant center performance.
    J Heart Lung Transplant. 2021 Aug 6. pii: S1053-2498(21)02446.
    PubMed     Abstract available


  13. CARDOSO B, Radhakrishnan S, Mazwi M, Mital S, et al
    Early treatment of thrombotic microangiopathy, a rare and serious complication after heart transplant.
    J Heart Lung Transplant. 2021 Aug 4. pii: S1053-2498(21)02444.
    PubMed    


    July 2021
  14. SINGH TP, Cherikh WS, Hsich E, Chambers DC, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report - 2021; focus on recipient characteristics.
    J Heart Lung Transplant. 2021 Jul 31. pii: S1053-2498(21)02439.
    PubMed    


  15. KHUSH KK, Hsich E, Potena L, Cherikh WS, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics.
    J Heart Lung Transplant. 2021 Jul 29. pii: S1053-2498(21)02432.
    PubMed    


  16. KHAN A, Pahl E, Koehl DA, Cantor RS, et al
    Improved heart transplant survival for children with congenital heart disease and heterotaxy syndrome in the current era: An analysis from the pediatric heart transplant society.
    J Heart Lung Transplant. 2021 Jul 23. pii: S1053-2498(21)02410.
    PubMed     Abstract available


  17. BROCH K, Brautaset Englund KV, Gullestad L
    Reply: Safety of intravenous iron in heart transplant patients: Comment to paper by Brautaset Englund et al.
    J Heart Lung Transplant. 2021 Jul 22. pii: S1053-2498(21)02409.
    PubMed    


  18. LI Y, Godown J, Taylor CL, Dipchand AI, et al
    Favorable outcomes after heart transplantation in Barth syndrome.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02394.
    PubMed     Abstract available


  19. ORTIZ-BAUTISTA C, Fernandez-Aviles F, Delgado Jimenez JF
    Serum biomarkers of acute rejection: Towards precision medicine in heart transplant.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02397.
    PubMed     Abstract available


  20. GIANGRECO NP, Lebreton G, Restaino S, Jane Farr M, et al
    Plasma kallikrein predicts primary graft dysfunction after heart transplant.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02391.
    PubMed     Abstract available


  21. MANTELL BS, Cordero H, See SB, Clerkin KJ, et al
    Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies.
    J Heart Lung Transplant. 2021 Jul 8. pii: S1053-2498(21)02387.
    PubMed     Abstract available


    June 2021
  22. SANTULARIO-VERDU L, Diez-Lopez C, Gonzalez-Costello J
    Safety of intravenous iron in heart transplant patients: Comment to paper by Brautaset Englund et al.
    J Heart Lung Transplant. 2021 Jun 29. pii: S1053-2498(21)02385.
    PubMed    


  23. BOCK MJ, Kuhn MA, Chinnock RE
    COVID-19 diagnosis and testing in pediatric heart transplant recipients.
    J Heart Lung Transplant. 2021 Jun 17. pii: S1053-2498(21)02361.
    PubMed     Abstract available


  24. ORESCHAK K, Saba LM, Rafaels N, Ambardekar AV, et al
    Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
    J Heart Lung Transplant. 2021 Jun 12. pii: S1053-2498(21)02342.
    PubMed     Abstract available


  25. BENCK L, Kransdorf EP, Emerson DA, Rushakoff J, et al
    Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    J Heart Lung Transplant. 2021 Jun 10. pii: S1053-2498(21)02346.
    PubMed     Abstract available


    May 2021
  26. SAADI TA, Lawrecki T, Narang N, Joshi A, et al
    Outcomes of pre- heart transplantation desensitization in a series of highly sensitized patients bridged with left ventricular assist devices.
    J Heart Lung Transplant. 2021 May 31. pii: S1053-2498(21)02341.
    PubMed     Abstract available


  27. ISSITT R, Booth J, Crook R, Robertson A, et al
    Intraoperative anti-A/B immunoadsorption is associated with significantly reduced blood product utilization with similar outcomes in pediatric ABO-incompatible heart transplantation.
    J Heart Lung Transplant. 2021 May 29. pii: S1053-2498(21)02325.
    PubMed     Abstract available


  28. MADAN S, Patel SR, Vlismas P, Hemmige V, et al
    Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.
    J Heart Lung Transplant. 2021 May 29. pii: S1053-2498(21)02328.
    PubMed     Abstract available


  29. GENUARDI MV, Moss N, Najjar SS, Houston BA, et al
    Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes.
    J Heart Lung Transplant. 2021 May 19. pii: S1053-2498(21)02319.
    PubMed     Abstract available


  30. SHAD R, Fong R, Quach N, Bowles C, et al
    Long-term survival in patients with post-LVAD right ventricular failure: multi-state modelling with competing outcomes of heart transplant.
    J Heart Lung Transplant. 2021 May 19. pii: S1053-2498(21)02316.
    PubMed     Abstract available


  31. SORBINI M, Togliatto GM, Simonato E, Boffini M, et al
    HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    J Heart Lung Transplant. 2021 May 14. pii: S1053-2498(21)02315.
    PubMed     Abstract available


  32. KIM ST, Helmers MR, Iyengar A, Smood B, et al
    Assessing predicted heart mass size matching in obese heart transplant recipients.
    J Heart Lung Transplant. 2021 May 12. pii: S1053-2498(21)02306.
    PubMed     Abstract available


  33. ZHU Y, Shudo Y, Lingala B, Joseph Woo Y, et al
    The impact of donor sex on heart transplantation outcomes-a study of over 60,000 patients in the United States.
    J Heart Lung Transplant. 2021 May 1. pii: S1053-2498(21)02302.
    PubMed     Abstract available


    April 2021
  34. AMDANI S, Boyle G, Rossano J, Scheel J, et al
    Association of low center performance evaluations and pediatric heart transplant center behavior in the United States.
    J Heart Lung Transplant. 2021 Apr 22. pii: S1053-2498(21)02279.
    PubMed     Abstract available


  35. PELED Y, Ram E, Lavee J, Sternik L, et al
    BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response.
    J Heart Lung Transplant. 2021 Apr 21. pii: S1053-2498(21)02274.
    PubMed     Abstract available


  36. IL'GIOVINE ZJ, Williams JB, Mason RP, Sherratt SCR, et al
    Kinetics of generic tacrolimus in heart transplantation: A cautionary note.
    J Heart Lung Transplant. 2021 Apr 17. pii: S1053-2498(21)02235.
    PubMed     Abstract available


  37. OLT C, Faulkenberg KD, Hsich EM
    The growing dilemma of legalized cannabis and heart transplantation.
    J Heart Lung Transplant. 2021 Apr 10. pii: S1053-2498(21)02265.
    PubMed     Abstract available


  38. SCHEUER SE, Jansz PC, Macdonald PS
    Heart transplantation following donation after circulatory death: Expanding the donor pool.
    J Heart Lung Transplant. 2021 Apr 8. pii: S1053-2498(21)02237.
    PubMed     Abstract available


  39. WANG B, Zhou Q, Li A, Li S, et al
    Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation.
    J Heart Lung Transplant. 2021 Apr 8. pii: S1053-2498(21)02266.
    PubMed     Abstract available


  40. PATEL JK, Kittleson MM
    The challenge of heart transplantation in sensitized patients-carfilzomib and the importance of shared experience.
    J Heart Lung Transplant. 2021 Apr 1. pii: S1053-2498(21)02264.
    PubMed    


  41. PAPPALARDO F, Morici N, Colombo PC
    MitraBridge and left ventricular assist device: Crossing dangerous bridges.
    J Heart Lung Transplant. 2021;40:316-317.
    PubMed    


    March 2021
  42. CARROZZINI M, Merlanti B, Olivieri GM, Lanfranconi M, et al
    Percutaneous RVAD with the Protek Duo for severe right ventricular primary graft dysfunction after heart transplant.
    J Heart Lung Transplant. 2021 Mar 25. pii: S1053-2498(21)02242.
    PubMed     Abstract available


  43. SANDER S, Singer-Englar T, Nishihara K, Esmailian F, et al
    Heart transplant in Jehovah's Witness patients: A case-control study.
    J Heart Lung Transplant. 2021 Mar 21. pii: S1053-2498(21)02240.
    PubMed     Abstract available


  44. BUCHAN TA, Moayedi Y, Truby LK, Guyatt G, et al
    Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2021 Mar 20. pii: S1053-2498(21)02241.
    PubMed     Abstract available


  45. GODINO C, Munafo AR, Scotti A, Saia F, et al
    Strategies for bridge to heart transplantation: Percutaneous mitral valve repair and LVAD.
    J Heart Lung Transplant. 2021 Mar 19. pii: S1053-2498(21)02238.
    PubMed    


  46. DOLGNER SJ, Nguyen VP, Krieger EV, Stempien-Otero A, et al
    Long-term adult congenital heart disease survival after heart transplantation: A restricted mean survival time analysis.
    J Heart Lung Transplant. 2021 Mar 13. pii: S1053-2498(21)02217.
    PubMed     Abstract available


  47. SRIWATTANAKOMEN R, Xu Q, Demehin M, Shullo MA, et al
    Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02218.
    PubMed     Abstract available


    February 2021
  48. SAMMOUR Y, Nassif M, Magwire M, Thomas M, et al
    Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence.
    J Heart Lung Transplant. 2021 Feb 22. pii: S1053-2498(21)02197.
    PubMed     Abstract available


  49. ADAMSON GT, Profita EL, Quinonez ZA, McElhinney DB, et al
    Alternative to heart-lung transplantation for end-stage tetralogy of Fallot with major aortopulmonary collaterals: Simultaneous heart transplantation and pulmonary artery reconstruction.
    J Heart Lung Transplant. 2021 Feb 17. pii: S1053-2498(21)02175.
    PubMed    


  50. KHUSH KK
    Clinical utility of donor-derived cell-free DNA testing in cardiac transplantation.
    J Heart Lung Transplant. 2021 Feb 4. pii: S1053-2498(21)01598.
    PubMed     Abstract available


    January 2021
  51. BRAUTASET ENGLUND KV, Ostby CM, Rolid K, Gude E, et al
    Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial.
    J Heart Lung Transplant. 2021 Jan 23. pii: S1053-2498(21)01422.
    PubMed     Abstract available


  52. LLOYD JW, Oh JK, Daly RC, Frantz RR, et al
    Clinical features and prognosis of surgically proven constrictive pericarditis after orthotopic heart transplantation.
    J Heart Lung Transplant. 2021 Jan 12. pii: S1053-2498(21)00013.
    PubMed     Abstract available


  53. LENG SX, Kittleson MM
    Beyond the eyeball test: Impact and potential mechanisms of frailty in heart transplant candidates.
    J Heart Lung Transplant. 2021 Jan 5. pii: S1053-2498(20)31869.
    PubMed    


  54. OFFOR UT, Bacon CM, Roberts J, Powell J, et al
    Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
    J Heart Lung Transplant. 2021;40:24-32.
    PubMed     Abstract available


  55. WANG L, MacGowan GA, Ali S, Dark JH, et al
    Ex situ heart perfusion: The past, the present, and the future.
    J Heart Lung Transplant. 2021;40:69-86.
    PubMed     Abstract available


  56. GOLDSTEIN DR
    A tough act to follow: Taking JHLT into the future.
    J Heart Lung Transplant. 2021;40:1-2.
    PubMed    


    December 2020
  57. ACUNA S, D'Souza R
    Pregnancy after heart transplantation: A second-generation transmission of the gift of life-in reply.
    J Heart Lung Transplant. 2020 Dec 31. pii: S1053-2498(20)31863.
    PubMed    


  58. SZUGYE NA, Zafar F, Ollberding NJ, Villa C, et al
    A novel method of donorrecipient size matching in pediatric heart transplantation: A total cardiac volumepredictive model.
    J Heart Lung Transplant. 2020 Dec 4. pii: S1053-2498(20)31827.
    PubMed     Abstract available


  59. MESSER S, Cernic S, Page A, Berman M, et al
    A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors.
    J Heart Lung Transplant. 2020;39:1463-1475.
    PubMed     Abstract available


  60. MEHRA MR, Costanzo MR
    Transcatheter mitral valve intervention in advanced heart failure.
    J Heart Lung Transplant. 2020;39:1363-1365.
    PubMed    


    November 2020
  61. CARRIER M, Moriguchi J, Shah KB, Anyanwu AC, et al
    Outcomes after heart transplantation and total artificial heart implantation: A multicenter study.
    J Heart Lung Transplant. 2020 Nov 28. pii: S1053-2498(20)31852.
    PubMed     Abstract available


  62. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    PubMed     Abstract available


  63. MACDONALD PS, Gorrie N, Brennan X, Aili SR, et al
    The impact of frailty on mortality after heart transplantation.
    J Heart Lung Transplant. 2020 Nov 21. pii: S1053-2498(20)31839.
    PubMed     Abstract available


  64. GONZALEZ MH, Acharya D, Lee S, Leacche M, et al
    Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
    J Heart Lung Transplant. 2020 Nov 9. pii: S1053-2498(20)31829.
    PubMed     Abstract available


  65. BENKE K, Jasz DK, Szilagyi AL, Barath B, et al
    Methane supplementation improves graft function in experimental heart transplantation.
    J Heart Lung Transplant. 2020 Nov 7. pii: S1053-2498(20)31828.
    PubMed     Abstract available


  66. FISHER AJ, Rogers JG
    The Journal of Heart and Lung Transplantation: A golden age draws to a close and a new dawn begins.
    J Heart Lung Transplant. 2020 Nov 2. pii: S1053-2498(20)31825.
    PubMed    


    September 2020
  67. PARIZO JT, Desai M, Rodriguez F, Sandhu AT, et al
    Evaluation of variation in insurance payor mix among heart transplant centers.
    J Heart Lung Transplant. 2020 Sep 30. pii: S1053-2498(20)31764.
    PubMed    


  68. PETERS LL, Ambardekar AV
    An immunosuppression tightrope: Successful heart transplantation after giant cell myocarditis in a patient with HIV complicated by recurrent giant cell myocarditis and Kaposi sarcoma.
    J Heart Lung Transplant. 2020 Sep 29. pii: S1053-2498(20)31761.
    PubMed    


  69. MOHEBALI D, Kobashigawa JA
    Cocaine use in heart transplant donors: A call to expand the donor pool.
    J Heart Lung Transplant. 2020 Sep 24. pii: S1053-2498(20)31757.
    PubMed    


  70. GODINO C, Munafo A, Scotti A, Estevez-Loureiro R, et al
    MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry.
    J Heart Lung Transplant. 2020 Sep 17. pii: S1053-2498(20)31745.
    PubMed     Abstract available


  71. BARGHASH MH, Taimur S, Rana M, Behar J, et al
    Recombinant herpes zoster vaccine after heart transplantation: A single-center experience.
    J Heart Lung Transplant. 2020 Sep 10. pii: S1053-2498(20)31720.
    PubMed    


  72. WOOLLEY AE, Singh SK
    The curious phenomenon of early cardiac allograft rejection with hepatitis Cinfected donor heart transplants.
    J Heart Lung Transplant. 2020 Sep 8. pii: S1053-2498(20)31721.
    PubMed    


  73. VIEIRA JL, Cherikh WS, Lindblad K, Stehlik J, et al
    Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis.
    J Heart Lung Transplant. 2020 Sep 2. pii: S1053-2498(20)31704.
    PubMed     Abstract available


  74. SINGHVI A, Barghash M, Lala-Trindade A, Mitter SS, et al
    Challenges in heart transplantation during COVID-19: A single-center experience.
    J Heart Lung Transplant. 2020;39:894-903.
    PubMed     Abstract available


    August 2020
  75. COOPER DKC
    Clinical trials of pig heart transplantation.
    J Heart Lung Transplant. 2020 Aug 29. pii: S1053-2498(20)31697.
    PubMed    


  76. MESSER S, Abu-Omar Y, Large SR, Berman M, et al
    Combined heart-lung transplantation from a donation after circulatory death donor.
    J Heart Lung Transplant. 2020 Aug 20. pii: S1053-2498(20)31696.
    PubMed     Abstract available


  77. STEHLIK J, Mehra MR
    Secular changes in organ donor profiles and impact on heart and lung transplantation.
    J Heart Lung Transplant. 2020 Aug 15. pii: S1053-2498(20)31693.
    PubMed    


  78. NANDI D, Chin C, Schumacher KR, Fenton M, et al
    Surveillance for cardiac allograft vasculopathy: Practice variations among 50 pediatric heart transplant centers.
    J Heart Lung Transplant. 2020 Aug 8. pii: S1053-2498(20)31692.
    PubMed     Abstract available


  79. KOHSAKA S, Shudo Y, Wang H, Lingala B, et al
    Long-term outcome of orthotopic heart transplantation in Asians: An analysis of the United Network of Organ Sharing database.
    J Heart Lung Transplant. 2020 Aug 6. pii: S1053-2498(20)31689.
    PubMed    


  80. PLATT JL, Piedrahita JA, Cascalho M
    Clinical xenotransplantation of the heart: At the watershed.
    J Heart Lung Transplant. 2020;39:758-760.
    PubMed    


  81. MCGUINTY C, Moayedi Y, Chih S
    Outcomes according to the International Society for Heart and Lung Tansplantation angiographic grading scale.
    J Heart Lung Transplant. 2020;39:847-848.
    PubMed    


    July 2020
  82. CHAMBERS DC, Zuckermann A, Cherikh WS, Harhay MO, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics.
    J Heart Lung Transplant. 2020 Jul 30. pii: S1053-2498(20)31661.
    PubMed    


  83. SINGH TP, Hsich E, Cherikh WS, Chambers DC, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics.
    J Heart Lung Transplant. 2020 Jul 24. pii: S1053-2498(20)31659.
    PubMed    


  84. LANDER MM
    Thyroid hormone in cardiac transplantation: Cat chasing its tail?
    J Heart Lung Transplant. 2020 Jul 23. pii: S1053-2498(20)31662.
    PubMed    


  85. KHUSH KK, Potena L, Cherikh WS, Chambers DC, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics.
    J Heart Lung Transplant. 2020 Jul 23. pii: S1053-2498(20)31660.
    PubMed    


  86. HAYES D JR, Harhay MO, Cherikh WS, Chambers DC, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report - 2020; focus on deceased donor characteristics.
    J Heart Lung Transplant. 2020 Jul 23. pii: S1053-2498(20)31658.
    PubMed    


  87. DEFILIPPIS EM, Kittleson MM
    Pregnancy after heart transplantation: A need for updated guidelines.
    J Heart Lung Transplant. 2020 Jul 15. pii: S1053-2498(20)31657.
    PubMed    


  88. GIDEA CG, Narula N, Reyentovich A, Fargnoli A, et al
    Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.
    J Heart Lung Transplant. 2020 Jul 8. pii: S1053-2498(20)31624.
    PubMed     Abstract available


  89. SOQUET J, Rousse N, Moussa M, Goeminne C, et al
    Heart retransplantation following COVID-19 illness in a heart transplant recipient.
    J Heart Lung Transplant. 2020 Jul 7. pii: S1053-2498(20)31648.
    PubMed    


  90. FELICELLI C, Lopez-Hisijos N, Omman R, Shepherd D, et al
    Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation.
    J Heart Lung Transplant. 2020 Jul 7. pii: S1053-2498(20)31651.
    PubMed    


  91. DALY KP
    The ABO-incompatible paradigm shifts only as far as allocation policy allows.
    J Heart Lung Transplant. 2020;39:636-638.
    PubMed    


  92. HANFF TC, Harhay MO, Kimmel SE, Birati EY, et al
    Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States.
    J Heart Lung Transplant. 2020;39:725-726.
    PubMed    


  93. PARKER WF, Churpek MM, Anderson AS
    Is it too early to investigate survival outcomes of the new US heart allocation system?
    J Heart Lung Transplant. 2020;39:726.
    PubMed    


  94. DAVIES RR, Goff RR, Lease ED, Daly RC, et al
    Commentary in reply to Cogswell et al.: An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.
    J Heart Lung Transplant. 2020;39:726-728.
    PubMed    


    June 2020
  95. IACOVONI A, Boffini M, Pidello S, Simonato E, et al
    A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy.
    J Heart Lung Transplant. 2020 Jun 26. pii: S1053-2498(20)31617.
    PubMed     Abstract available


  96. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis.
    J Heart Lung Transplant. 2020 Jun 21. pii: S1053-2498(20)31608.
    PubMed     Abstract available


  97. CASTELLANI C, Burrello J, Fedrigo M, Burrello A, et al
    Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant.
    J Heart Lung Transplant. 2020 Jun 20. pii: S1053-2498(20)31610.
    PubMed     Abstract available


  98. NAPOLI C, Maiello C
    Careful clinical evaluation of donor fraction cell-free DNA in rejection surveillance after heart transplantation.
    J Heart Lung Transplant. 2020 Jun 20. pii: S1053-2498(20)31605.
    PubMed    


  99. KADOSH BS, Pavone J, Wu M, Reyentovich A, et al
    Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.
    J Heart Lung Transplant. 2020 Jun 7. pii: S1053-2498(20)31574.
    PubMed    


  100. CONSTANSO-CONDE I, Hermida-Prieto M, Barge-Caballero E, Nunez L, et al
    ORIGINAL CLINICAL SCIENCECirculating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation.
    J Heart Lung Transplant. 2020 Jun 7. pii: S1053-2498(20)31581.
    PubMed     Abstract available


  101. JANG K, Khatri A, Majure DT
    COVID-19 leading to acute encephalopathy in a patient with heart transplant.
    J Heart Lung Transplant. 2020 Jun 6. pii: S1053-2498(20)31576.
    PubMed    


  102. TZATZAKI E, Spartalis E, Spartalis M
    Pregnancy after heart transplantation: A second-generation transmission of the gift of life.
    J Heart Lung Transplant. 2020 Jun 5. pii: S1053-2498(20)31573.
    PubMed    


    May 2020
  103. WINGO M, de Biasi AR, Shudo Y, Bharathi V, et al
    Cardiac transplantation for cancer involving the heart.
    J Heart Lung Transplant. 2020 May 24. pii: S1053-2498(20)31562.
    PubMed    


  104. REICHART B, Langin M, Radan J, Mokelke M, et al
    Pig-to-non-human primate heart transplantation: The final step toward clinical xenotransplantation?
    J Heart Lung Transplant. 2020 May 15. pii: S1053-2498(20)31556.
    PubMed     Abstract available


  105. WALSH MN, Ravichandran AK, Seasor E, Salerno CT, et al
    Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID-19.
    J Heart Lung Transplant. 2020 May 11. pii: S1053-2498(20)31552.
    PubMed    


  106. CHEN CY, Chen SF, Hollander SA, Rosenthal D, et al
    Donor heart selection during the COVID-19 pandemic: A case study.
    J Heart Lung Transplant. 2020;39:497-498.
    PubMed    


  107. LI F, Cai J, Dong N
    First cases of COVID-19 in heart transplantation from China.
    J Heart Lung Transplant. 2020;39:496-497.
    PubMed    


  108. REN ZL, Hu R, Wang ZW, Zhang M, et al
    Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.
    J Heart Lung Transplant. 2020;39:412-417.
    PubMed     Abstract available


  109. SIDDIQI HK, Mehra MR
    COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.
    J Heart Lung Transplant. 2020;39:405-407.
    PubMed    


  110. MADAN S, Patel SR, Jorde UP
    Donor heart with low ejection fraction: Challenges of multiple hits.
    J Heart Lung Transplant. 2020;39:500.
    PubMed    


  111. LIAO T, Li Q, Zhang Y, Yang Z, et al
    Precise treatment of acute antibody-mediated cardiac allograft rejection in rats using C4d-targeted microbubbles loaded with nitric oxide.
    J Heart Lung Transplant. 2020;39:481-490.
    PubMed     Abstract available


    April 2020
  112. RUSSELL MR, Halnon NJ, Alejos JC, Salem MM, et al
    COVID-19 in a pediatric heart transplant recipient: Emergence of donor-specific antibodies.
    J Heart Lung Transplant. 2020 Apr 29. pii: S1053-2498(20)31532.
    PubMed    


  113. HOLM AM, Mehra MR, Courtwright A, Teuteberg J, et al
    Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement.
    J Heart Lung Transplant. 2020 Apr 25. pii: S1053-2498(20)31531.
    PubMed     Abstract available


  114. LEVY L, Huszti E, Renaud-Picard B, Berra G, et al
    Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    J Heart Lung Transplant. 2020 Apr 19. pii: S1053-2498(20)31520.
    PubMed     Abstract available


  115. AMBROSI P
    Comment on "Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China" by Ren et al.
    J Heart Lung Transplant. 2020 Apr 11. pii: S1053-2498(20)31509.
    PubMed    


  116. ADAMSON MB, Ribeiro RVP, Yu F, Lazarte J, et al
    Human leukocyte antigen-G donor-recipient matching of the 14-base pair polymorphism protects against cancer after heart transplant.
    J Heart Lung Transplant. 2020 Apr 7. pii: S1053-2498(20)31485.
    PubMed     Abstract available


  117. WALDMAN G, Bethea E, Gustafson J, Cote M, et al
    Use of Crushed Glecaprevir/Pibrentasvir in Hepatitis C Positive Donor Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  118. POGLAJEN G, Zemljic G, Frljak S, Okrajsek R, et al
    Prolonged Release Tacrolimus Has Comparable Safety and Efficacy Profile as Standard Release Tacrolimus in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  119. ORESCHAK K, Saba LM, Deininger KM, Ambardekar AV, et al
    Association between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  120. DEW MA, DeVito Dabbs AJ, DiMartini AF, Ma Y, et al
    Health-Related Quality of Life Impairments and Benefits 15-19 Years after Lung or Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  121. LICHSCHEIDT ED, Jespersen NR, Nielsen BR, Berg K, et al
    Mitochondrial Function is Impaired in Heart Transplant Patients with Cardiac Allograft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  122. LIN CM, Mehrad B, Gill RG
    The Natural Killer Cell Receptor NKG2D is Critical to Antibody-Mediated Chronic Rejection in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  123. POWER A, Sweat KR, Hollander SA, Schmidt J, et al
    Waitlist Mortality in US Children Listed for Heart Transplant - Where are We Now?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  124. AMDANI S, Staffa SJ, Zurakowski D, Ramakrishnan K, et al
    ABO Incompatible Heart Transplantation in Pediatric Recipients with High Isohemagglutinin Titers in the U.S.: A Multi-Institutional Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  125. BOGLE C, Cantor R, Koehl D, Lochridge J, et al
    Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  126. BEARL DW, Cantor R, Koehl D, Gossett JG, et al
    Heart Transplant Outcomes in Children with Fontan-Associated Plastic Bronchitis: A Pediatric Heart Transplant Society Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  127. LIU GS, Wolfson AM, Genyk PA, Vucicevic D, et al
    Outcomes of HIV-Positive Patients Post Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  128. ROEST S, Nous FM, van Dijkman ED, Attrach M, et al
    Use of Cardiac CT in the Routine Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results from the First 100 Consecutive Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  129. NAGUMO S, Gallinoro E, Candreva A, Mizukami T, et al
    Virtual Fractional Flow Reserve in Heart Transplant Recipients with and without Graft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  130. ASLEH R, Briasoulis A, Smith B, Lopez C, et al
    Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  131. NELSON LM, Rossing K, Boesgaard S, Gustafsson F, et al
    Early IVUS-Guided Selection for Non-Invasive Cardiac Allograft Vasculopathy (CAV) Screening in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  132. LEACCHE M, Boeve TJ, Manandhar Shrestha N, Kelty CE, et al
    Changing Landscape of Heart Transplantation in the US after Implementation of the New Allocation System: A UNOS Data Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  133. XIA Y, Regalie W, Nsair A, Ardehali A, et al
    Characteristics and Outcomes of Heart Transplants Following the Change in UNOS Allocation Policy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  134. RAMZY D, Esmailian F, Emerson D, Megna D, et al
    The New UNOS Heart Allocation Changes Significantly Changed the Landscape of Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  135. CASCINO T, Stehlik J, Cherikh W, Cheng Y, et al
    Mechanical Circulatory Support Use in the Context of Updated Heart Transplant Allocation Policy in the U.S. - Analysis of OPTN Data.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  136. HANFF TC, Harhay MO, Kimmel SE, Molina M, et al
    The Role of Human Leukocyte Antigen Sensitization as a Risk Factor for Mortality in Patients Bridged to Heart Transplantation with VA-ECMO.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  137. PUREWAL S, Moayedi Y, Runeckles K, Fan C, et al
    Are Two Tests Better Than One? Combining Donor Derived Cell-Free DNA and Gene Expression Profiling for Non-Invasive Surveillance after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  138. HEDE S, Fraschilla S, Alejos JC
    Development and Utility of a Novel Post-Operative Pediatric Heart Transplant Clinical Pathway.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  139. GRIFFITHS ER, Schumacher K, DiPaola F, Chen S, et al
    The Fontan Liver after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  140. KEMNA MS, Shaw D, Ameduri R, Azeka E, et al
    Posterior Reversible Encephalopathy Syndrome (PRES) after Pediatric Heart Transplantation: A Multicenter Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  141. BRUSCA SB, Jang MK, Shah P, Shah KB, et al
    Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  142. BUDDE R, Nous F, Roest S, Constantinescu A, et al
    Non-Invasive Functional Coronary Artery Evaluation by CT-Derived Fractional Flow Reserve (FFRct) in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  143. CLERKIN KJ, Fried JA, Griffin JM, Restaino SW, et al
    Impact of Time Post-Heart Transplant on Myocardial Flow Reserve and Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  144. WAN N, Travin M, Luke A, Gjelaj C, et al
    Poor Glycemic Control Correlates with Worse Myocardial Flow Measured by Ammonia-13 Positron Emission Tomography in Cardiac Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  145. CLERKIN KJ, Griffin JM, Fried JA, Restaino SW, et al
    Myocardial Flow Reserve by N13 Ammonia Positron Emission Tomography Predicts Post-Heart Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  146. FEDRIGO M, Bottigliengo D, Romano A, Gugole E, et al
    Clinical Relevance of Vasculitis in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  147. GLASS C, Davis R, Xiong B, Dov D, et al
    The Use of Artificial Intelligence (AI) Machine Learning to Determine Myocyte Damage in Cardiac Transplant Acute Cellular Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  148. HALLORAN PF, Reeve J, Aliabadi A, Cadeiras M, et al
    Mapping the Injury Phenotypes of Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  149. GANAPATHI AM, Whitson BA, LaFrancesca S, McLaughlin B, et al
    The Effect of Donor Heart Risk Factors on Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  150. FIEDLER AG, Smith JW, Raza F, Hermsen JL, et al
    Significant Regional Variability Yet Similar Survival in Heart Transplantation Utilizing Increased Risk Donor Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  151. MASETTI M, Moretta A, Sabatino M, Russo A, et al
    Pulmonary Vascular Resistances among Heart Transplant Candidates: Are We Looking to the Right Player?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  152. SEESE L, Aranda-Michel E, Huckaby L, Keebler M, et al
    Development and Validation of a Risk Score to Predict One-Year Mortality after Bridge to Heart Transplantation with Contemporary Durable Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  153. HO S, Ly P, Riesgo-Gil F, Dar O, et al
    Incidence and Risk Factors for Neutropenia in Adult Heart Transplant Recipients: Single Centre Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  154. BOYLE K, Pollack A, Brinkley D
    Lymphocyte Suppression in Heart Transplant Recipients after Thymoglobulin Dosing Based on CD3+ Lymphocyte Counts.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  155. KIM M, Givertz MM, Stewart GC, Page DS, et al
    Efficacy and Safety of LCP-Tacrolimus (Envarsus XR(R)) Conversion Therapy in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  156. JENNINGS DL, Salerno D, Lange N, Clerkin KJ, et al
    Faster Time-to-Therapeutic Tacrolimus Level is Associated with Lower Risk of Cellular Rejection Early after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  157. LAU RP, Sosa RA, Fishbein GA
    Sarcolemmal Staining by Anti-C4d/C3d in Cardiac Transplant Endomyocardial Biopsies and Associated Serum HLA Antibodies and Pathologic Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  158. WESTON M, Rinde-Hoffman D, Berman P, Arroyo L, et al
    Heart Transplant Patients with PAMR1(H+) and PAMR2 Rejection Have the Same Amount of Myocardial Injury by Molecular Microscope.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  159. FEDRIGO M, Carrozzini M, Bocca T, Bottigliengo D, et al
    Rejection Profile on Endomyocardial Biopsy in the Follow Up of Heart Transplanted Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  160. VAN DEN HOOGEN P, Huibers MM, van den Dolder FW, de Weger RA, et al
    Plasma Immunoglobulin Levels Prior to Cardiac Transplantation are Associated with Post-Transplantation Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  161. MILLER RJ, Hedman K, Vrotec B, Ingelsson E, et al
    Novel Methods for Donor and Recipient Size Matching in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  162. FORSBERG A, Paulsson A, Ragntoft C, Dalvindt M, et al
    Fear of Graft Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  163. DALVINDT M, Nozhoor S, Kisch A, Forsberg A, et al
    Chronic Pain One to Five Years after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  164. BARRETT AL, Gilbert KE, Hope K, Spinner JA, et al
    Think Ahead! A Quality Improvement Initiative for Advance Directives in Young Adult Heart Transplant Recipients at a Pediatric Center.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  165. BARTEN MJ, Hua X, Bernhardt A, Rybczynski M, et al
    Optimal Dosing of Cyclosporine and Tacrolimus to Improve Medication Adherence after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  166. MABASA AC, Kleet AC, Gaine M, Lee JC, et al
    Follow-Up Phone Calls are Effective in Increasing Compliance with Screening for De Novo Cancer among Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  167. BURNETTE AL, Henderson HT, Adams VL, Savage AJ, et al
    The Use of Concurrent Home Hospice for Pediatric Heart Failure Patients Awaiting Heart Transplant on Milrinone and/or Ventricular Assist Device.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  168. ROLID K, Andreassen AK, Yardley M, Bjorkelund E, et al
    Benefits of High-Intensity Interval Training in a Young and in an Older De Novo Heart Transplant Recipient- Cases from the HITTS Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  169. GRANEY N, Paliga R, Siemeck R, Glowacki N, et al
    Impact of Ventricular Assist Device Infection Severity on 1-Year Survival after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  170. TRUJILLO D, Ruiz L, Jaramillo A, Alejandro C, et al
    Survival in the First Year of Heart Transplantation in a Center of a Developing Country, Infection versus Rejection as Causes of Mortality.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  171. RAHMAN F, Dunn D, Baneman E, Sullivan T, et al
    Strongyloides Screening in Heart Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  172. CHOW JK, Ruthazer R, Boucher HW, Nierenberg N, et al
    Factors Associated with Neutropenia Post-Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  173. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Long-Term Survival Outcomes after Heart Transplantation in Patients with Chagas Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  174. PIECHURA LM, Harloff MT, Keshk M, Ogawa M, et al
    A Contemporary Analysis of the Safety and Efficacy of Cardiac Transplantation from Donors with Blood Infections.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  175. ORTIZ-GONZALEZ Y, Yip DS, Patel PC, Leoni-Moreno JC, et al
    Evaluation of Infection Risk Based on Induction Immunotherapy within the First Year after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  176. NGUYEN A, Rodgers D, Imamura T, Besser S, et al
    Prevalence of BK Virus Infection in a Large Heart Transplant Population.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  177. FUJINO T, Kumai Y, Nitta D, Lourenco L, et al
    Hypogammaglobulinemia Following Heart Transplantation - Prevalence and Clinical Importance.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  178. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  179. PELED Y, Lavee J, Maor E, Freimark D, et al
    Hepatitis B Seropositivity is Associated with Increased Cardiac Allograft Vasculopathy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  180. KITTLESON M, Patel J, Chang D, Nishihara K, et al
    Effect of the Shingles Vaccine in Altering Clinical Shingles after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  181. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    The Forgotten Hepatitis B Donor in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  182. RAVICHANDRAN R, Itabashi Y, Liu W, Mohanakumar T, et al
    Role for Circulating Exosomes with Cardiac Self-Antigens (Myosin and Vimentin) in the Pathogenesis of Chronic Rejection in a Murine Heterotopic Model of Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  183. MANTELL BS, Cordero H, See S, Clerkin K, et al
    RNA Expression Analysis of Antibody Mediated Rejection after Heart Transplant with or without Donor Specific Antibodies.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  184. ZAR G, Vihinen M, Nilsson J
    Identify New Genetic Variants on Chromosome 6 Associated with Mortality after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  185. KOPECKY B, Lavine K
    Investigating the Roles of Donor Macrophages after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  186. DESHPANDE SR, Simpson PM, Zhang L, -Mitchell AT, et al
    Natural History of Hemodynamic Maturation Post Heart Transplantation in the Absence of Rejection.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  187. KIRK C, Tong M, Shivaram G, Law Y, et al
    Herding CATs? The Incidence and Prevention of Catheter-Associated Thromboses (CATs) in Pediatric Patients after Cardiac Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  188. HOPE KD, Choudhry S, Puri K, Spinner JA, et al
    Atypical Infiltrates on Endomyocardial Biopsy are Associated with Adverse Outcomes in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  189. IQBAL MS, Zhang Y, Dykes J, Almond C, et al
    Impact of Insurance Status on Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  190. BHIMANI S, Boyle G, Liu W, Worley S, et al
    Gender and Racial Disparities in Pediatric Heart Transplantation in the Current Era: A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  191. BARKOFF LM, Dykes JC, Maeda K, Hollander SA, et al
    Taking a Closer Look at Distance: Does Increasing the Maximal Donor Distance Range Shorten Waitlist Times in Pediatric Heart Transplant Candidates?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  192. RATHGEBER SL, Hutchison S, De Souza AM, Timothy O, et al
    Using Text Messaging to Communicate with Adolescent Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  193. KUHN MA, Chau P, Gordon BR, Martens TP, et al
    Utility of Early Intravascular Ultrasound after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  194. DAS BB, Winchester R, Niu J
    Is There Any Role of Gene Expression Profiling Test in Asymptomatic Pediatric Heart Transplant Recipients?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  195. PADILLA MMM, Hayes E, Hodge A, Meyer E, et al
    A Comparison of Intra-Operative Human Leukocyte Antigen Antibody Removal Techniques in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  196. JASSERON C, Audry B, Cantrelle C, Legeai C, et al
    Pediatric Heart Transplantation in France Since the Implementation of the New Allocation System.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  197. THANGAPPAN K, Haney L, Zafar F, Hossain M, et al
    What are the Expectations for Length of Stay after Pediatric Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  198. MOKSHAGUNDAM D, Castleberry CD, Simpson KE, Ybarra AM, et al
    Treatment and Pattern of Resolution of Antibody-Mediated Rejection with Hemodynamic Compromise Resistant to Standard Therapy after Heart Transplantation with a Positive Virtual Crossmatch.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  199. MAGNETTA DA, Thrush PT, Monge MC, Khan A, et al
    Insurance Type and Impact on Waitlist Mortality in Young Heart Transplant Candidates: A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  200. LUNZE FI, Singh TP, Harrild D, Gauvreau K, et al
    Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  201. WEISERT MA, Harake D, Hede S, Russell M, et al
    A Multicenter Survey on Post-Transplant Lymphoproliferative Disorders in Pediatric Heart Transplant Recipients: A Case for Development of Consensus Guidelines for Screening, Surveillance and Treatment?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  202. SPINNER JA, Chen X, Denfield SW, Dreyer WJ, et al
    Intestinal Microbiome Composition Changes after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  203. CHAU P, Fitts JA, Tan R, Bock MJ, et al
    Comparison of Sirolimus and Everolimus on Hematologic Parameters in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  204. DUONG S, Hall M, Hollander SA, Thurm C, et al
    Impact of High- vs. Low-Frequency Surveillance Endomyocardial Biopsy Strategy in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  205. FRANDSEN EL, Hingorani SR, Jorgensen N, Albers EL, et al
    Prevalence and Risk Factors of Proteinuria in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  206. LAMBERT AN, Weiner J, Hall M, Thurm C, et al
    Heart Transplant Outcomes in Children with Ebstein's Anomaly.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  207. JACKSON R, Heyrend C, Fullerton C, Benefield E, et al
    Safety and Efficacy of CD3 Guided Anti-Thymocyte Globulin Dosing after Pediatric Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  208. LAKS JA, Kiss A, Dipchand AI
    Immune Dysregulation after Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  209. HAYES EA, Hodge A, Meyer E, Nichol K, et al
    A Comparison of Intra-Operative Isohemagglutinin Removal Techniques in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  210. MCGOVERN E, Hirsch R, Chin P, Morales DL, et al
    Quantitative Coronary Angiography Can Predict Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  211. MCGILL M, Evans M, Schmidt S, Griselli M, et al
    Relationship between Right Atrial Pressure and Inferior Vena Cava Dimensions in Pediatric Post Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  212. O'CONNOR MJ, Restaino K, Burstein DS, Rossano JW, et al
    Temporal Trends in Financing of Pediatric Heart Transplantation in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  213. AHMED H, Lee J, Profita E, Dykes J, et al
    Heightened Immune Response and Increased Risk of Infections in Pediatric Fontan Patients after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  214. FRANDSEN EL, Banker KA, Mazor RL, Law YM, et al
    When No VAD is the Right VAD: Medical Management of Critically Ill Infants Awaiting Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  215. CHEN S, Murray JM, Dykes J, Kaufman BD, et al
    Clinical Deterioration in Single Ventricle Infants Waiting for Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  216. YOUN J, Seguchi O, Cole R, Geft D, et al
    Desensitization in Mechanical Circulatory Support Patients Awaiting Heart Transplantation: What is the Post-Transplant Outcome?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  217. DENG B, Kawabori M, Shindgikar P, Hironaka C, et al
    The Effect of Left Thoracotomy LVAD Implantation to LVAD Surgery and Followed Heart Transplantation Surgery.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  218. NISHIDA H, Jeevanandam V, Koda Y, Song T, et al
    Impact of Prophylactic Donor Heart Tricuspid Valve Annuloplasty in Long-Term Clinical Outcomes of Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  219. HUSSAIN Z, Yu MD, Wozniak A, Kim D, et al
    Impact of Donor Smoking History on Post Heart Transplant Outcomes: A Propensity Matched Analysis of the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  220. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Donor Thyroid Hormone Therapy and Heart Transplantation Outcomes: An Analysis of the ISHLT Registry Data.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  221. VIEIRA JL, Cherikh WS, Lindblad K, Stehlik J, et al
    Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  222. ESMAILIAN FA, Emerson D, Megna D, Ramzy D, et al
    Heart Transplantation with Older Donors: Should There Be an Age Cutoff.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  223. HARLOFF M, Piechura L, Percy E, Hirji S, et al
    Safety of Mechanical Support via the Axillary Artery as a Bridge to Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  224. ZHU Y, Shudo Y, Lingala B, Elde S, et al
    The Impact of Donor Gender on Heart Transplantation Outcomes - A Study of over 60,000 Patients in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  225. ALEKSOVA N, Billia F, Foroutan F, Buchan TA, et al
    Extracorporeal Membrane Oxygenation for Early Graft Dysfunction Following Heart Transplantation: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  226. TRAMMELL J, Epstein FR, Liu C, Dobbels F, et al
    Gender Differences in Adherence to Nonpharmacologic Recommendations after Heart Transplant: A Secondary Analysis from the International BRIGHT Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  227. KUMAI Y, Takeda K, Roth Z, Fried J, et al
    Residual Lung Injury Following HeartMate 3 Explantation for Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  228. SEGUCHI O, Youn J, Geft D, Cole R, et al
    The Burden of Total Artificial Heart Patients and Complications after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  229. PELED Y, Ram E, Kogan A, Rozenman J, et al
    Explantation of Left Ventricular Assist Device as Bridge Therapy is Associated with Diaphragm Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  230. FRANKEL WC, Godfrey EL, Suarez EE, Rana A, et al
    Data-Driven Volume Thresholds Predictive of Improved Outcomes after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  231. FOLEY NM, Hardin M, Park B, Rahaman Z, et al
    Veteran Affairs Partnership Improves Access to High Volume, Quality Heart Transplant Programs. It Ain't Broke!
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  232. KREBS R, Kankainen M, Syrjala S, Nykanen A, et al
    Platelet Transcriptome as a Marker for Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  233. HOE LES, Wells MA, Bouquet M, Hyslop K, et al
    Metabolic and Mitochondrial Alterations Following Brain Death and Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  234. BENKE K, Ruppert M, Sayour AA, Jasz D, et al
    Methane-Enriched Custodiol Preservation Solution Improves Graft Function in Experimental Model of Heterotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  235. EMMANUEL S, Pearman M, Jansz P, Hayward C, et al
    Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  236. MUSLEM R, Yalcin YC, Yasar YE, Roest S, et al
    Impact of Left Ventricular Assist Device on Renal Function Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  237. KEARNS MJ, Chou L, Aguillon M, Passano E, et al
    Impella 5.0 as a Bridge to Cardiac Transplantation before and after Reclassification of the United Network for Organ Sharing Heart Allocation Criteria.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  238. LEVA E, Syrjala S, Kytola S, Kankainen M, et al
    Donor-Derived Cell-Free DNA as an Early Noninvasive Biomarker of Cardiac Allograft Injury and Rejection in Human Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  239. RAVI Y, Chinta V, Zaver SM, Balasubramaniyan JV, et al
    Do Post- Heart Transplant Placement of Permanent Pacemakers Affect Survival?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  240. BROWN KD, Cooper C, Arce-Esquivel AA, Gottlieb RL, et al
    Impact of Ischemic Time on Functional Exercise Capacity after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  241. MORENO J, Verma A, Kopecky B, Dehner C, et al
    Angiotensin II Type 1 Receptor Antibody Mediated Rejection Following Orthotopic Heart Transplant: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  242. BOEKEN U, Aubin H, Mehdiani A, Bottger C, et al
    Levosimendan Treatment in Patients with Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  243. KITTLESON M, Patel J, Chang D, Nishihara K, et al
    Longer-Term Morbidity/Mortality of Severe Left Ventricular Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  244. KITTLESON M, Patel J, Chang D, Kransdorf E, et al
    Outcome of Right Ventricular Primary Graft Dysfunction after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  245. KRISHNAMOORTHY B, Mehta V, Critchley WR, Callan P, et al
    Clinical Outcomes and Financial Implications of Using Extra Corporeal Membrane Oxygenation (ECMO) for Primary Graft Dysfunction Following Heart Transplantation: A Single Centre Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  246. PELED Y, Ram E, Kogan A, Kassif Y, et al
    Spontaneous Restoration of Sinus Rhythm during Heart Transplantation is Associated with a Reduced Incidence of Primary Graft Dysfunction and Early Mortality.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  247. LIM S, Chue CD, Mukadam ME, Quinn D, et al
    Cardiac Power Output Index to Define Severe Graft Dysfunction in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  248. BOUNADER K, Flecher E, Chabanne C, Lelong B, et al
    Ratio of Pulmonary Artery Diameter to Ascending Aortic Diameter as a Predictive Tool for Severe Primary Graft Dysfunction in Heart Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  249. VILLELA MA, Bravo CA, Shah M, Patel S, et al
    Prediction of Outcomes after Heart Transplantation Using Machine Learning Techniques.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  250. SHAH M, Villela MA, Bravo C, Castellanos A, et al
    Impact of Donor Hemodynamics on Heart Transplant Outcomes: Using Machine Learning Techniques.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  251. SHAH M, Patel S, Saeed O, Pirlamarla P, et al
    Impact of Center Heart Transplant Volume on One-Year Survival or Retransplantation: A 2006 to 2016 UNOS Based Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  252. CHAND RR, Vaidya AS, Lum CJ, Vucicevic D, et al
    Heart Transplantation Mortality in Recipients with Muscular Dystrophy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  253. SINGHVI A, Araujo-Gutierrez R, Bhimaraj A, Park MH, et al
    Influence of HLA-DR Mismatches on Long Term Outcomes Following Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  254. SYMALLA T, Song T, Ota T, Mirzai S, et al
    Negative Outcomes Associated with Reoperative Sternotomy and LVAD Explantation at the Time of Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  255. URBAN M, Lundgren S, Siddique A, Lowes B, et al
    Long-Term Outcome of Heart Transplant Recipients with Acute Graft Dysfunction Requiring Temporary Mechanical Circulatory Support.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  256. KAWABORI M, Critsinelis AC, Nordan T, Chen FY, et al
    UNOS Registry Study: The Impact of Preoperative Mechanical Circulatory Support Devices to Heart Transplant Outcomes in over 78,000 Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  257. VEEN K, Papageorgiou G, Zijderhand C, Brugts J, et al
    The Clinical Impact and Long-Term Outcome of Tricuspid Regurgitation in Patients with Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  258. RAVI Y, Zaver SM, Emani S, Lei D, et al
    Education and Its Impact on Post-Heart Transplant Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  259. ESMAILIAN F, Emerson D, Megna D, Ramzy D, et al
    The Outcome of Redo Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  260. JOCHER B, Nakajima T, Tanaka Y, Fischer I, et al
    Incidence and Risk Factors for Acute Kidney Injury Post-Heart Transplant: An Analysis of Peri-Operative Hemodynamics.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  261. GIBLIN G, Murphy L, Mahon N, Chughtai Z, et al
    Survival Trends Post Cardiac Transplantation: A Comparative Analysis of Irish and International Data (1985-2019).
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  262. PATEL J, Kittleson M, Kransdorf E, Chang D, et al
    The Natural History of Pre-Existing Donor Specific Antibody and Amnestic Responses after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  263. SONG W, Chen Q, Patel C, Yang Q, et al
    Pre-Formed Donor-Specific Antibodies Impact Long Term Survival of Heart Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  264. CHUN K, Lee C, Oh J, Park S, et al
    Increased Aortic Stiffness Index is Associated with Reduced Exercise Capacity Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  265. BOTTA L, Murana G, Fiorentino M, Marianna B, et al
    Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  266. JELENC M, Jelenc B, Vrtovec B, Knezevic I, et al
    Impact of Mechanical Circulatory Support and Heart Transplantation on Survival of the Population of Transplant Eligible Advanced Heart Failure Patients - A Computer Simulation Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  267. KHUSH K, Kao A, Eisen H, Hall S, et al
    Gene Expression Profile Scores by Allomap(R) are Higher in Heart Transplant Patients with Non-Skin Cancer Malignancy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  268. ESMAILIAN F, Emerson D, Megna D, Ramzy D, et al
    Pre-Heart Transplant Glomerular Filtration Rate and Outcome.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  269. ALI J, Mann S, Smith F, Rushton S, et al
    Recipient Age, Not Donor Age, Impacts on Long Term Outcomes Following Heart Transplantation: A 23-year National Analysis from the United Kingdom.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  270. NYGAARD SI, Rolid K, Nytroen K, Fiane A, et al
    Heart Rate Response after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  271. ARAUJO-GUTIERREZ R, Bhimaraj A, Guha A, Hussain I, et al
    No Increase in Infections or Readmissions in Al Amyloid Patients Who Undergo Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  272. D'ANGELO A, Naka Y, Sanchez J, Kaku Y, et al
    Outcomes of Mechanical Circulatory Support Therapy for Cardiogenic Shock Associated with Late Allograft Failure after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  273. MAZZONE S, Fujino T, Nguyen A, Chung B, et al
    Post-Heart Transplant Diabetes Mellitus: Incidence, Prevalence and Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  274. ESMAILY S, Dellgren G, Bobbio E, Nilsson J, et al
    Patient Outcomes after Heart Transplantation in Sweden between 1988 and 2017: Continuous Improvement in Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  275. LEE J, Cho Y, Park I
    Heart Transplantation Bridged by Extracorporeal Life Support in the Korean Adults: A 15 Year Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  276. VENEMA CS, Erasmus ME, Mariani M, Voors AA, et al
    Inotrope Score as a Predictor of Outcome after Adult Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  277. CHANG E, Moayedi Y, Hoppenfeld M, Lafreniere-Roula M, et al
    Malignancy Following Heart Transplant: Few and Far Between.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  278. NISHIDA H, Ota T, Koda Y, Onsager D, et al
    Long Term Survival after Heart Transplantation is Not Affected by Axillary Intra Aortic Balloon Pump Support as a Bridge to Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  279. LUNDGREN S, Lowes B, Lyden E, Zolty R, et al
    Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  280. SON AY, Karim AS, Cerier E, Bharadwaj SN, et al
    Outcomes of Heart Transplantation Bridging Strategies: Durable VAD vs IABP vs Medical Therapy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  281. DE LA ROSA A, Aguilar J, Barbu A, Chang D, et al
    Uniqueness of Laryngeal Nerve Injury Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  282. OH G, Lee H, Oh J, Cho H, et al
    Role of Anti-Vimentin Antibodies in Pre-Sensitized Korean Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  283. VOJNIKA J, Vishnevsky A, Shah M, Farzad D, et al
    A Novel Immunosuppressive Regiment for Cardiac Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  284. VAISHNAV E, Pham D, Hess T, Baber A, et al
    Impact of Induction Therapy in Cardiac Transplant Patients in the Current Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  285. NGUYEN VN, Burt CA, Adler E, Pretorius VG, et al
    Evaluation of Induction Strategies in Heart Transplant at a Single Center.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  286. DELA CRUZ M, Besser S, Sarswat N, Smith B, et al
    Immune Function Testing and Donor-Specific Antibody Production among Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  287. SCATOLA A, Nnani D, Sun E, Alvarez C, et al
    Sirolimus Therapy and Risk of Late Cellular Rejection in Heart Transplant Patients with Cardiac Allograft Vasculopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  288. COOPER LB, Cochrane A, Cherikh W, Toll AE, et al
    Induction Therapy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  289. STERLING S, Soto-Arenall M, Goswami R, Patel P, et al
    Evaluation of the Efficacy and Safety of Dual Induction versus Induction Monotherapy in Orthotopic Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  290. SAADI TA, Andrade A, Munro J, Khan M, et al
    Outcomes of Pre- Heart Transplantation Desensitization in Highly Sensitized Patients Bridged with Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  291. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    Does the Dose of Mycophenolate Mofetil Impact Outcome after Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  292. KOBASHIGAWA JA, Kittleson M, Chang DH, Kransdorf E, et al
    Post-Heart Transplant Outcomes of Sensitized Patients Who Have Undergone Desensitization Therapy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  293. MINATO C, Nasri A, Carrier M, White M, et al
    Rapid Weaning of Steroids after Cardiac Transplantation Improves Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  294. FUKUSHIMA N, Yanase M, Watanabe T, Kuroda K, et al
    Mid-Term Effectiveness of Everolimus on Heart Transplant Recipients with Renal Dysfunction or Transplant Coronary Artery Atherosclerosis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  295. RODRIGUEZ JBC, Argueta E, Santana HM, Lenneman A, et al
    Incidence and Onset of Leukopenia in Adults the First Year after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  296. BARTEN MJ, Hong J, Hua X, Bernhardt A, et al
    Long-Term Results of Everolimus on Renal Function and Rejection after Heart Transplantation in a Real-Life Scenario.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  297. PATEL J, Kittleson M, Chang DH, Nishihara K, et al
    5-Year Outcome of Patients Weaned off Corticosteroids after Heart Transplantation: Is There a Downside?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  298. PATEL J, Kittleson M, Kransdorf E, Shen A, et al
    Does the Development of Donor Specific Antibody after Heart Transplantation Depend on the Presence or Absence of Corticosteroids as Maintenance Therapy?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  299. NATTIV J, Banankhah P, Liu GS, Genyk PA, et al
    Outcomes Using Veno-Arterial Extra-Corporeal Membrane Oxygenation as a Bridge to Heart Transplantation Following the UNOS Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  300. PANDYA K, Rahman J, Vaidya A, Fong M, et al
    Utilization of Public Health Service Increased Risk Donors in Heart Transplantation and Outcomes: UNOS Registry Review.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  301. GONCALVES FAR, Trindade EM, Mangini S, Gaiotto F, et al
    Impact of Histidine-Tryptophan-Ketoglutarate Preservation Solution in Heart Transplantation with Extended Distance.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  302. FIEDLER AG, Smith JW, Raza F, Hermsen JL, et al
    Differences in Heart Transplant Volume Growth and Outcomes among Low and High Volume Centers.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  303. STINSON G, Patel PC, Yip DS, Leoni-Moreno JC, et al
    Assessment of Aortic Root Size in Donor Heart Predicts Short and Long Term Recipient Outcomes after Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  304. FIEDLER AG, Lushaj EB, Dhingra R, Hermsen JL, et al
    30 Day Survival in Heart Transplant Patients Bridged with Short Term Mechanical Circulatory Support: Are We Failing to Rescue?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  305. KAO A, Wells R, May A, Markham L, et al
    The Effect of the New UNOS Heart Allocation on Donation Service Area and Heart Transplant Program Logistics: The Mid America Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  306. MAGRUDER J, Sperry A, Vasquez CR, Smood BF, et al
    Impact of Multiorgan Procurement on Survival Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  307. EMERSON D, Megna D, Cole R, Levine R, et al
    Does Brain Death Related to Underlying Donor Disease Correlate with Adverse Outcomes after Heart Transplant?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  308. MURANA G, Fiorentino M, Gliozzi G, Botta L, et al
    Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  309. RAMZY D, Esmailian F, Emerson D, Megna D, et al
    Has the New Heart Transplant Donor Allocation Policy Affected Immediate Post-Transplant Care and Outcomes? A Single Center Perspective.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  310. PELED Y, Ram E, Kogan A, Kassif Y, et al
    Combined Procurement of Heart and Lungs is Associated with an Increased Risk of Primary Graft Dysfunction after Heart Transplantation Compared to Isolated Heart Procurement.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  311. GUPTA N, McDonald MA, Kobashigawa JA, Ross HJ, et al
    Cannabis Use and Heart Transplantation: A Canadian Perspective.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  312. LIU G, Wolfson AM, Nattiv J, Genyk P, et al
    Post-Transplant Outcomes for Patients Based on Their Duration of Smoking Cessation at the Time of Heart Transplant (HT) Listing.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  313. KINGSFORD P, Li JP, Wolfson AM, Nattiv J, et al
    Heart Transplantation Outcomes in Multiorgan Transplants.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  314. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Comparison of Six-Month Outcomes in Patients Bridged to Heart Transplantation with an Intra-Aortic Balloon Pump before and after the UNOS Allocation System Change.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  315. PANDYA K, Vaidya A, Cheng R, Baran D, et al
    Management of Cardiac Sarcoidosis Post Heart Transplantation: Survey of Transplant Centers.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  316. LI JP, Kingsford P, Grazette L, Nattiv J, et al
    Heart Transplant Outcomes for Patients with Myocarditis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  317. SANDOVAL E, Perdomo J, Pereda D, Quintana E, et al
    Has Short-Term Mechanical Circulatory Support an Impact on Post-Heart Transplant Vasoplegia?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  318. AMERI AS, Absi DO, Renedo MF, Giordanino EF, et al
    Outcomes of Heart Transplant in a Sensitized Latin American Population.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  319. AL-SAFFAR F, Hsu J, Fuentes J, Smith J, et al
    Combined AlloSure and AlloMap Testing in Multi-Organ Heart Transplantation Rejection Surveillance.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  320. VAIDYA G, Luthringer D, Czer L
    Giant Cell Myocarditis: Excellent Outcome after Heart Transplant Using Anti-Thymocyte Globulin.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  321. GEORGE S, Horstmanshof DA, Phancao AA, Bedard RA, et al
    Absolute Lymphocyte Count as a Surrogate for Lymphocyte Phenotype Analysis of CD3 Count in Monitoring Thymoglobulin Response Post Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  322. OH J, Chun K, Lee C, Park S, et al
    Morning Surge Was Related with Increased Arterial Stiffness in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  323. GENUARDI MV, Zhang Y, Mazurek JA, Hanff TC, et al
    Peak Oxygen Consumption and Survival after Heart Transplant is Similar in Patients with and without Comorbid Obstructive Sleep Apnea.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  324. KIM H, Kim J, Joo H, Lee S, et al
    The Predictive Scoring Systems for Outcomes of Heart Transplantation in Patients with Pre-Existing Liver Cirrhosis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  325. KARIM AM, Aljammal M, Panhwar MS, Kalra A, et al
    Impact of Malnutrition and Interventions on Patients Receiving Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  326. PINSINO A, Jennings DL, Mahoney I, Sweat A, et al
    Serum Cystatin C versus Creatinine Based Assessment of Renal Function in Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  327. GUPTA R, Punnoose LR, Marvin-Peek J, Schlendorf KH, et al
    Trends in Blood Urea Nitrogen to Creatinine Ratio between Listing and Heart Transplant are Associated with Poor Post-Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  328. GUPTA R, Schlendorf KH, Shah A, Punnoose LR, et al
    Trends in MELD-XI between Listing and Transplant are Associated with Poor Outcomes in Heart Transplant Recipients with Stage 3 Chronic Kidney Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  329. KODEBOINA M, Verstreken S, Goethals M, Dierckx R, et al
    Hemodynamic Response to Acute Volume Load in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  330. KIM D, Choi J, Cho H, Jung S, et al
    The Prognostic Importance of Perioperative Renal Function and Outcome of Patients Undergoing Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  331. KAO A, Linard J, Austin BA, Everley MP, et al
    The Combined Use of Gene Expression Profile and Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients: The Mid America Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  332. PELED Y, Lavee J, Ram E, Kassif Y, et al
    Left Atrial Volume after Heart Transplantation - A Predictor of Outcomes?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  333. MEGNA D, Emerson D, Cole R, Levine R, et al
    Orthotopic Heart Transplantation in the Diabetic Patient, are We Still Worried? A Review of 952 Consecutive Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  334. GUPTA R, Punnoose LR, Marvin-Peek J, Schlendorf KH, et al
    Blood Urea Nitrogen to Creatinine Ratio at Listing is Associated with Poor Outcomes in Heart Transplant Recipients with Stage 3 Chronic Kidney Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  335. CHAND RR, Vaidya AS, Lum CJ, Vucicevic D, et al
    Comparing Mortality in Heart Transplantation Utilizing Donor Hearts with and without CAD.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  336. MANING J, Blumer V, Chaparro S
    Protective Effects of Combined Heart Transplantation on Cardiac Allograft Vasculopathy: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  337. ALAM A, Dib E, Zafar H, Felius J, et al
    Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  338. DEFILIPPIS EM, Clerkin KJ, Griffin JM, Fried JA, et al
    Sex Differences in Myocardial Flow Reserve by Positron Emission Tomography in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  339. BJERRE KP, Clemmensen TS, Poulsen SH, Hvas A, et al
    Micro and Macrovascular Cardiac Allograft Vasculopathy in Relation to 92 Cardiovascular Biomarkers Evaluated by a Novel Proximity Extension Assay in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  340. ALHARETHI R, Mason S, Knight S, Min D, et al
    Global Coronary Artery Flow Reserve after Heart Transplantation: Recipient or Donor Age-Driven?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  341. LECHIANCOLE A, Sponga S, Vendramin I, Ferrara V, et al
    Coronary Artery Disease of the Donor Graft: Any Impact on Survival and Cardiac Allograft Vasculopathy after Heart Transplantation?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  342. PATEL J, Kittleson M, Chang D, Nishihara K, et al
    Pre-Transplant Collagen Vascular Disease as a Risk Factor for Increase in Cardiac Allograft Vasculopathy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  343. GRIFFIN JM, Clerkin KJ, Fried JA, Latif F, et al
    Concordance between Coronary Artery Calcium and Coronary Angiography in the Detection of Cardiac Allograft Vasculopathy in Post Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  344. PELED Y, Eilon R, Maor E, Einhorn M, et al
    High Serum Phosphate is Associated with Increased Cardiac Allograft Vasculopathy and Adverse Cardiac Events Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  345. ALVAREZ CK, Nnani D, Patel SR, Goldstein D, et al
    Post-Transplant Diabetes Mellitus and the Risk of Acute Rejection in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  346. GIBLIN G, Murphy L, Mahon N, McCarthy J, et al
    Prevalence of Acute Cellular Rejection and Its Impact on Survival Post Heart Transplantation in the Contemporary Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  347. DOSHI AH, Tushak Z, Kong H, Garcia V, et al
    Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  348. SOBIESZCZANSKA-MALEK M, Oleksiak A, Kruk M, Kepka C, et al
    Dynamic Computed Tomography Perfusion for Diagnosis of Cellular Rejection after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  349. LUKAC J, Syrjala S, Saraswat M, Joenvaara S, et al
    Plasma Protein Signature during Ischemia-Reperfusion Injury in Clinical Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  350. BACAL DC, Silva MMF, de Jesus MS, Bacal F, et al
    C-reactive Protein and Left Ventricular Thickness Can Predict Acute Cellular Rejection after Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  351. HOLMSTROM E, Syrjala S, Krebs R, Nykanen A, et al
    Nitric Oxide Inhalation is Associated with Decreased Incidence of Acute Rejection after Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  352. IUS F, Sommer W, Rojas SV, Kaufeld T, et al
    Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  353. MOAYEDI Y, Fan CS, Purewal S, Han J, et al
    Acute Cellular Rejection after Heart Transplantation Dramatically Subsequent Risk of Mortality, Particularly among African Americans.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  354. AIKEN A, Patel J, Kransdorf E, Shen A, et al
    Donor Specific Antibodies after Heart Transplantation: Can They Be Treated?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  355. POGLAJEN G, Frljak S, Zemljic G, Okrajsek R, et al
    Clinical Effects of CD34(+) Cell Therapy in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  356. ZAVER SM, Wan JY, Lei D, Whitson BA, et al
    Improving Heart Transplant Outcomes in the African American Population? Are We There Yet?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  357. DE OLIVEIRA FM, Ikeda ET, Avila M, Wozniak I, et al
    Prevalence of Cognitive Impairment in Heart Transplant Waiting-List Patients in a Developing Country.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  358. PARIZO J, Khush K
    Donor Derived Cell Free DNA Levels are Predictive of Clinical Events in Stable Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  359. GOURZI P, Pantou MP, Gkouziouta A, Chaidaroglou A, et al
    Can Genetic Profile of Patients Undergoing Heart Transplantation Alter Clinical Decisions?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  360. HUPF JC, Onat D, Javaid A, Mondellini GM, et al
    Association of Plasma Trimethylamine-N-oxide and Serum Endothelin-1 with Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  361. SINGHVI A, Araujo-Gutierrez R, Park MH, Bhimaraj A, et al
    Prognostic Value of Dobutamine Stress Echocardiography in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  362. MARSH KM, Mehaffey J, Krebs ED, Beller JP, et al
    Long Term Employment Following Heart Transplantation in the United States.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  363. KENNEDY CC, Lee M, Hathcock M, Thompson K, et al
    Self-Management Ability is an Indirect Mediator of Quality of Life in Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  364. GOEKLER J, Zuckermann A, Worel N, Ceran E, et al
    Extracorporeal Photopheresis Immediately after Heart Transplantation in High Risk Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  365. GENYK P, Nuno SB, Hashmi S, Nattiv J, et al
    Heart Transplant Outcomes in Patients with Alcoholic Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  366. KURIATA J
    Circulating miRNA 208a Reflect Early Myocardial Injury and Recovery after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  367. KAINUMA A, Sanchez J, Ning Y, Nemeth SK, et al
    Contemporary Outcomes of Heart Transplantation in Adult Patients with Congenital Heart Disease and Prior Intracardiac Repair: Analysis from UNOS Database.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  368. DIAMANT MJ, Fox AL, Modi VA, Joshi AA, et al
    No Survival Benefit Associated with Waiting for Non-Lung Donor Heart Transplants for Recipients with Adult Congenital Heart Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  369. SURYAPALAM M, Kashem MA, Zhao H, Sunagawa G, et al
    Heart Transplantation in Elderly Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  370. KITTLESON M, Patel J, Kransdorf E, Shen A, et al
    Is Anti-Thymocyte Globulin for Sensitized Patients Undergoing Heart Transplantation Effective?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  371. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Clinical Predictors, Regional Variation and Temporal Trends of Weight Gain after Heart Transplant: An Analysis of the ISHLT Transplant Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  372. GENYK PA, Nattiv J, Liu GS, Banankhah P, et al
    Heart Transplantation Outcomes in Patients with Marfan Syndrome: UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  373. PELED Y, Beigel R, Klempfner R, Lavee J, et al
    Prevalence and Clinical Predictors of Aspirin Resistance in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  374. LIU Y, Padilla FA, Graviss EA, Nguyen D, et al
    Heart Transplant Outcomes in Obese Patients BMI 35-39.9.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  375. ROLID K, Andreassen AK, Yardley M, Bjorkelund E, et al
    Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 3-year Results from the HITTS Randomized Controlled Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  376. JENNINGS DL, Pinsino A, Mahoney I, Sweat A, et al
    Use of Serum Cystatin C versus Creatinine for Estimation of Renal Function and Valganciclovir Dosing in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  377. GENYK PA, Liu GS, Nattiv J, Banankhah P, et al
    Heart Transplantation Outcomes in Adults with Postpartum Cardiomyopathy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  378. NAKANO SJ, Zhou J, Nunley K, Beatty J, et al
    Polyfunctional CD8+ T Cells are Associated with Biopsy Proven Acute Cellular Rejection in Pediatric Heart Transplant Patients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  379. DESHPANDE SR, Alsoufi B, Sinha P, Amdani S, et al
    Do Expanded Donor Criteria Impact Outcomes in Pediatric Heart Transplantation? A UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  380. RASKIN A, Borsheim K, Kim M, Brickler M, et al
    Plasma Induced Transcriptional Analysis Assessment of Rejection in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  381. THANGAPPAN K, Morales DL, Lehenbauer D, Villa C, et al
    Impact of Mechanical Circulatory Support on Pediatric Heart Transplant Candidates with Elevated Pulmonary Vascular Resistance.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  382. HANERHOFF MC, Dreyer WJ, Denfield SW, Choudhry S, et al
    Assessment of Mycophenolic Acid Levels on Biopsy Proven Rejection and Adverse Effects in Pediatric Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  383. SALAH LM, Oreschak K, Ambardekar AV, Page RL 2nd, et al
    Effect of CYP3A Genetic Variants on Different Measures of Tacrolimus Variability in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  384. SRIWATTANAKOMEN R, Xu Q, Zeevi A, Demehin M, et al
    Carfilzomib for Heart Transplant Desensitization.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  385. WALDMAN G, Gift T, Turvey K, Ho JE, et al
    Optimal Dosing of Enoxaparin to Achieve Therapeutic Anticoagulation in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  386. ZELLERS TM, Daneman S, Butts R
    Gene Expression Profiling Scores (Allomap) Can Successfully Predict the Absence of Serious Rejection in a Pediatric Heart Transplant Population; Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  387. ALMOND C, Sleeper LA, Rossano JW, Pahl E, et al
    The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  388. THANGAPPAN K, Price N, Zafar F, Alsaied T, et al
    Congenital Heart Disease and a Single Lung: Is Heart Transplantation Alone an Option?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  389. TOWNSEND ML, Karamlou T, Boyle GJ, Feingold B, et al
    Brighter Future for Children with Congenital Heart Disease Requiring Heart Transplantation? A UNOS Registry Analysis over the Last Three Decades.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  390. SIROTA M, Heyrend C, Ou Z, Masotti S, et al
    Tacrolimus Trough Variability- Predictors and Outcomes in Pediatric Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  391. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  392. BARGHASH MH, Taimur S, Rana M, Behar J, et al
    Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  393. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  394. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  395. ADLAM JP, Morris K, Salerno CT, Walsh MN, et al
    First Reported Treatment Failure in a Recipient of a Hepatitis C Viremic Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  396. XIN L, Yao W, Yu F, Ribeiro RV, et al
    Comparison of Lactate and Glucose during Ex Situ Heart Perfusion as Predictors of Early-Stage Heart Transplantation Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  397. BANANKHAH P, Nattiv J, Liu GS, Genyk PA, et al
    Six-Month Outcomes for Patients Bridged to Heart Transplantation with Veno-Arterial Extra-Corporeal Membrane Oxygenation before and after the Heart Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  398. LIU G, Wolfson AM, Nattiv J, Genyk PA, et al
    Comparison of Six-Months Outcomes in Patients Bridged to Heart Transplant with Inotropes before and after UNOS Heart Allocation Policy Change.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  399. GENYK PA, Nattiv J, Liu GS, Vucicevic D, et al
    Outcomes of Heart Transplantation in Adults with Congenital Heart Disease Since UNOS Allocation System Change: UNOS Registry Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  400. GENYK PA, Liu GS, Nattiv J, Banankhah P, et al
    Heart Transplant Outcomes in Patients Who Receive Hepatitis B Virus (HBV) Positive Donor Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  401. MORRIS KL, Adlam JP, Haleem A, Patel A, et al
    Tacrolimus Levels after Direct Acting Anti-Viral Therapy in Hepatitis C Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  402. WU R, Weston M, Lunz JG, Lopez-Cepero M, et al
    A Mismatch Made in Medicine: Potential Implications of HLA DQ Epitope Mismatching Following Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  403. CHATURVEDI A, Patel K, Vashistha K, Kanwar M, et al
    Post-Cardiac Transplant Lymphocytic Thyroiditis Secondary to Amiodarone Use in the Pre-Transplant Period.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  404. MOSCARELLO TG, Moayedi Y, Caleshu C, Khush K, et al
    You Can't Find What You Aren't Looking For: Over Half of Heart Transplant Patients Have Moderate or Strong Likelihood of Genetic Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  405. GOLDWATER D, Ventigan N, Shih L, Jaladanki S, et al
    Feasibility of Incorporating Frailty Testing into Standard Assessment of Heart Transplant Candidacy.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  406. EDELSON JB, Edwards JJ, Katcoff H, Mondal A, et al
    Comparing Resource Use and Outcomes between Patients with Ventricular Assist Devices and Orthotopic Heart Transplant in the United States from 2006-2014: A Nationally Representative Sample of Emergency Department Visits.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  407. LIM S, Shaw S, Venkateswaran R, Abu-Omar Y, et al
    HeartMate 3 Compared to Heart Transplant Outcomes in England.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  408. TIBREWALA A, Khush KK, Cherikh W, Foutz J, et al
    Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  409. CHEN Y, Chi N, Wang C, Yu H, et al
    Double Bridge May Result Similar 3-year Outcome after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  410. BUCHAN TA, Moayedi Y, Truby LK, Posada JD, et al
    Incidence and Impact of Primary Graft Dysfunction in Adult Heart Transplant Recipients: A Systematic Review and Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  411. BRAUTASET ENGLUND KV, Ostby CM, Vartdal T, Rolid K, et al
    Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients (IronIC) - A Randomized, Double Blind, Controlled Trial.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  412. LIU GS, Wolfson AM, Nattiv J, Genyk PA, et al
    Heart Transplant Outcomes for Patients with Cardiac Sarcoidosis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  413. PELED Y, Ram E, Klempfner R, Lavee J, et al
    Weight Gain Following Heart Transplantation is Associated with Increased Risk of Rejection and Allograft Vasculopathy: An Analysis of the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  414. PUNNOOSE L, Coscia LA, Kliniewski D, Constantinescu S, et al
    Update on Pregnancy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  415. AGASTHI P, Smith SD, Murphy KM, Buras MR, et al
    Artificial Intelligence Helps Predict 5-year Mortality and Graft Failure in Patients Undergoing Orthotopic Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  416. POPTSOV VN, Spirina EA, Dogonascheva AA
    Five Years Experience of Peripheral Veno-Arterial ECMO as Method of Mechanical Circulatory Support in Heart Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  417. HANFF TC, Harhay MO, Kimmel SE, Molina M, et al
    VA-ECMO as a Bridge to Heart Transplantation: Quantification of Mortality Trends over the Last Decade.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  418. NILSSON J, Jernryd V, Qin G, Paskevicius A, et al
    Non-Ischemic Heart Preservation versus Static Cold Storage in Human Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  419. PAGE A, Messer S, Berman M, Kaul P, et al
    Heart Transplantation from Donation after Circulatory Determined Death: The Royal Papworth Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  420. GANAPATHI AM, Whitson BA, Lampert B, McLaughlin B, et al
    Impact of Preoperative Mechanical Support Following Heart Transplant.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  421. ROCHLANI YM, Miller A, Nnani D, Oh KT, et al
    Mycophenolate Mofetil Dose and Early Acute Cellular Rejection Post Cardiac Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  422. UYANIK-UENAL K, Perkmann-Nagele N, Wittmann F, Ceran E, et al
    Torque Teno Virus DNA Load after Heart Transplantation and Its Association with the Strength of Immunosuppression: Preliminary Data of a Prospective Single Center Study.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  423. KUNO T, Ueyama H, Takagi H, Alvarez P, et al
    Comparative Outcomes of Maintenance Immunosuppression Regimens in Heart Transplantation: Insights from Network Meta-Analysis.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  424. KIM I, Rossano JW, Kim H, Kim J, et al
    Predictors and Clinical Outcomes of Lymphoproliferative Disorders in Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  425. GIULIANO K, Canner JK, Etchill EW, Suarez-Pierre A, et al
    De Novo Malignancy after Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  426. WINGO M, de Biasi AR, Shudo Y, Lingala B, et al
    Cardiac Transplantation for Cancer Involving the Heart: Results from 35 Years of Transplants from the ISHLT Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  427. KADOSH B, Gidea C, Reyentovich A, Razzouk L, et al
    Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  428. STACHEL MW, Gidea CG, Katz S, Narula N, et al
    Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors - One-Year Follow-Up.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  429. LI SS, Moonsamy P, Osho A, Mohan N, et al
    Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  430. NATTIV J, Liu GS, Banankhah P, Genyk PA, et al
    Intermediate Survival Outcomes after Heart Transplantation Using Donor HCV NAT Positive Hearts.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  431. ALTSHULER PJ, Helmers M, Iyengar A, Han J, et al
    HCV Seropositive Donors Positively Impact Heart Transplantation Rates and Waitlist Mortality without Compromising Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  432. URIEL N, Benza R, Raval N
    The Effect of Pre-Transplant Mechanical Circulatory Support Devices on the Post-Transplant dd-cfDNA and GEP in Heart Transplantation.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  433. HUCKABY LV, Aranda-Michel E, Seese LM, Keebler M, et al
    Contemporary Sex-Based Outcomes after Orthotopic Heart Transplantation for Patients Bridged with Newer Generation Left Ventricular Assist Devices.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


    March 2020
  434. AHLUWALIA M, Givertz MM, Mehra MR
    Bariatric surgery and heart transplantation outcomes: A note of caution.
    J Heart Lung Transplant. 2020 Mar 29. pii: S1053-2498(20)31472.
    PubMed    


  435. MILLER RJH, Khush KK, Haddad F
    In Reply to Tumin et al.
    J Heart Lung Transplant. 2020;39:285-286.
    PubMed    


  436. KOBAYASHI J, Luo S, Akazawa Y, Parker M, et al
    Flow-targeted pediatric ex vivo heart perfusion in donation after circulatory death: A porcine model.
    J Heart Lung Transplant. 2020;39:267-277.
    PubMed     Abstract available


  437. TARAZON E, Corbacho-Alonso N, Barderas MG, Gil-Cayuela C, et al
    Plasma CD5L and non-invasive diagnosis of acute heart rejection.
    J Heart Lung Transplant. 2020;39:257-266.
    PubMed     Abstract available


  438. DAVILA AB, Shih W, Stoletniy LN, Martens TP, et al
    Increased sensitivity to ischemic interval of donor hearts with diminished left ventricular function.
    J Heart Lung Transplant. 2020;39:241-247.
    PubMed     Abstract available


    February 2020
  439. URSCHEL S, McCoy M, Cantor RS, Koehl DA, et al
    A current era analysis of ABO incompatible listing practice and impact on outcomes in young children requiring heart transplantation.
    J Heart Lung Transplant. 2020 Feb 28. pii: S1053-2498(20)31394.
    PubMed     Abstract available


  440. RAJAB TK, Jaggers J, Campbell DN
    Donation after circulatory death determination pediatric heart transplantation and 10-year outcomes.
    J Heart Lung Transplant. 2020 Feb 20. pii: S1053-2498(20)31403.
    PubMed    


  441. PUNNOOSE LR, Coscia LA, Armenti DP, Constantinescu S, et al
    Pregnancy outcomes in heart transplant recipients.
    J Heart Lung Transplant. 2020 Feb 13. pii: S1053-2498(20)31391.
    PubMed     Abstract available


  442. HUNT G, Gay P, Carlo WF
    True, maybe true, perhaps unrelated - granulocyte colony-stimulating factor and increased risk of rejection in heart transplant recipients.
    J Heart Lung Transplant. 2020 Feb 1. pii: S1053-2498(20)31366.
    PubMed    


  443. ACUNA S, Zaffar N, Dong S, Ross H, et al
    Pregnancy outcomes in women with cardiothoracic transplants: A Systematic review and meta-analysis.
    J Heart Lung Transplant. 2020;39:93-102.
    PubMed     Abstract available


  444. ADAM N, Coutance G, Viailly PJ, Drieux F, et al
    Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection.
    J Heart Lung Transplant. 2020;39:115-124.
    PubMed     Abstract available


    January 2020
  445. KIRK R, Dipchand AI, Davies RR, Miera O, et al
    ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation.
    J Heart Lung Transplant. 2020 Jan 31. pii: S1053-2498(20)31363.
    PubMed     Abstract available


  446. SHAH M, Saeed O, Shin J, Murthy S, et al
    Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    J Heart Lung Transplant. 2020 Jan 31. pii: S1053-2498(20)31357.
    PubMed     Abstract available


  447. KIRKLIN JK, Pagani FD, Goldstein DJ, John R, et al
    American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
    J Heart Lung Transplant. 2020 Jan 23. pii: S1053-2498(20)31346.
    PubMed    


  448. ANDO M, Takeda K, Kurlansky PA, Garan AR, et al
    Association between recipient blood type and heart transplantation outcomes in the United States.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30008.
    PubMed     Abstract available


  449. HENRICKSEN EJ, Tremblay-Gravel M, Moayedi Y, Yang W, et al
    Use of direct oral anticoagulants after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30009.
    PubMed    


  450. POGLAJEN G, Zemljic G, Frljak S, Cerar A, et al
    QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30010.
    PubMed    


  451. VENTURA HO, Eisen H
    When good intentions turn bad: A need for course correction.
    J Heart Lung Transplant. 2020;39:5-6.
    PubMed    


  452. COGSWELL R, John R, Estep JD, Duval S, et al
    An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.
    J Heart Lung Transplant. 2020;39:1-4.
    PubMed    


    December 2019
  453. BANSAL N, Wasserstein MP, Shah AM, Beddows K, et al
    Ventricular assist device bridge to heart transplantation in a child with homocystinuria.
    J Heart Lung Transplant. 2019 Dec 28. pii: S1053-2498(19)31809.
    PubMed    


    November 2019
  454. RICHMOND ME, Zangwill SD, Kindel SJ, Deshpande SR, et al
    Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.
    J Heart Lung Transplant. 2019 Nov 29. pii: S1053-2498(19)31767.
    PubMed     Abstract available


  455. XIE A, Yan H, Fu J, He A, et al
    T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation.
    J Heart Lung Transplant. 2019 Nov 26. pii: S1053-2498(19)31769.
    PubMed     Abstract available


  456. EDWARDS JJ, Seliktar N, White R, Heron SD, et al
    Impact and predictors of positive response to desensitization in pediatric heart transplant candidates.
    J Heart Lung Transplant. 2019;38:1206-1213.
    PubMed     Abstract available


  457. HOLZHAUSER L, Imamura T, Bassi N, Fujino T, et al
    Increasing heart transplant donor pool by liberalization of size matching.
    J Heart Lung Transplant. 2019;38:1197-1205.
    PubMed     Abstract available


  458. KITAI T, Okamoto T, Miyakoshi C, Niikawa H, et al
    Impact of combined heart and lung transplantation on bronchiolitis obliterans syndrome, cardiac allograft vasculopathy, and long-term survival.
    J Heart Lung Transplant. 2019;38:1170-1177.
    PubMed     Abstract available


    October 2019
  459. TCHANA-SATO V, Ledoux D, Vandendriessche K, Van Cleemput J, et al
    First report of a successful pediatric heart transplantation from donation after circulatory death with distant procurement using normothermic regional perfusion and cold storage.
    J Heart Lung Transplant. 2019;38:1112-1115.
    PubMed     Abstract available


  460. KHUSH KK, Cherikh WS, Chambers DC, Harhay MO, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.
    J Heart Lung Transplant. 2019;38:1056-1066.
    PubMed    


  461. ROSSANO JW, Singh TP, Cherikh WS, Chambers DC, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match.
    J Heart Lung Transplant. 2019;38:1028-1041.
    PubMed    


  462. CHAMBERS DC, Cherikh WS, Harhay MO, Hayes D Jr, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match.
    J Heart Lung Transplant. 2019;38:1042-1055.
    PubMed    


  463. HAYES D JR, Cherikh WS, Chambers DC, Harhay MO, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric lung and heart-lung transplantation report-2019; Focus theme: Donor and recipient size match.
    J Heart Lung Transplant. 2019;38:1015-1027.
    PubMed    


    September 2019
  464. SINGH TP
    Black race and outcomes in children with a heart transplant.
    J Heart Lung Transplant. 2019 Sep 25. pii: S1053-2498(19)31688.
    PubMed    


  465. WANG H, Shudo Y, MacArthur JW, Woo YJ, et al
    Heart-lung transplantation with concomitant aortic arch reconstruction for Eisenmenger syndrome and type B interrupted aortic arch.
    J Heart Lung Transplant. 2019 Sep 11. pii: S1053-2498(19)31669.
    PubMed    


    August 2019
  466. VAN KEER JM, Van Aelst LNL, Rega F, Droogne W, et al
    Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    J Heart Lung Transplant. 2019 Aug 10. pii: S1053-2498(19)31623.
    PubMed     Abstract available


    January 2019
  467. RAO V
    Continuing the battle against cardiac allograft vasculopathy: Does immunosuppression matter or is it a lipid issue?
    J Heart Lung Transplant. 2019;38:102-103.
    PubMed    


  468. CONWAY J, Tunuguntla H
    Impact of disease process on post-transplant outcomes: Protein-losing enteropathy in Fontan patients.
    J Heart Lung Transplant. 2019;38:3-4.
    PubMed    


  469. SCHUMACHER KR, Yu S, Butts R, Castleberry C, et al
    Fontan-associated protein-losing enteropathy and postheart transplant outcomes: A multicenter study.
    J Heart Lung Transplant. 2019;38:17-25.
    PubMed     Abstract available


    October 2018
  470. GOLDFARB SB, Hayes D Jr,, Levvey BJ, Cherikh WS, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first Pediatric Lung and HeartLung Transplantation Report-2018; Focus Theme: Multiorgan Transplantation.
    J Heart Lung Transplant. 2018;37:1196-1206.
    PubMed    


  471. CHAMBERS DC, Cherikh WS, Goldfarb SB, Hayes D Jr, et al
    The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation.
    J Heart Lung Transplant. 2018;37:1169-1183.
    PubMed    


  472. STEHLIK J, Chambers DC, Zuckermann A, Mehra MR, et al
    Increasing complexity of thoracic transplantation and the rise of multiorgan transplantation around the world: Insights from the International Society for Heart and Lung Transplantation Registry.
    J Heart Lung Transplant. 2018;37:1145-1154.
    PubMed    


    September 2018
  473. KULKARNI HS, Cherikh WS, Chambers DC, Garcia VC, et al
    Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    J Heart Lung Transplant. 2018 Sep 25. pii: S1053-2498(18)31663.
    PubMed     Abstract available


    April 2018
  474. ASLAM S, Xie R, Cowger J, Kirklin JK, et al
    Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality.
    J Heart Lung Transplant. 2018 Apr 25. pii: S1053-2498(18)31436.
    PubMed     Abstract available


  475. SKORO-SAJER N, Gerges C, Gerges M, Panzenbock A, et al
    Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.
    J Heart Lung Transplant. 2018 Apr 25. pii: S1053-2498(18)31433.
    PubMed     Abstract available


    March 2018
  476. FRIED JA, Nair A, Takeda K, Clerkin K, et al
    Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock.
    J Heart Lung Transplant. 2018 Mar 20. pii: S1053-2498(18)31396.
    PubMed     Abstract available


  477. PRADERE P, Tudorache I, Magnusson J, Savale L, et al
    Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.
    J Heart Lung Transplant. 2018 Mar 15. pii: S1053-2498(18)31388.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Heart Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: